A Multicenter Randomized, Double-blind, Placebo-controlled Study of MP-435 in Combination With MTX in Patients With Rheumatoid Arthritis - Exploratory Study.
Phase of Trial: Phase II
Latest Information Update: 18 Nov 2014
At a glance
- Drugs MP 435 (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 07 Jun 2017 Biomarkers information updated
- 21 Mar 2012 Actual patient number 112 added as reported by ClinicalTrials.gov.
- 21 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.